4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012324
Director sold 400,000 shares at $1.00 ($400,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Javitt Jonathan C Director | 2022-12-07 | Sale | −400,000 | $1.00 | $400,000 | 12,899,997 | I |
| Open-market sales · 400,000 sh · avg $1.00 · $400,000 | |||||||
Loading xslF345X03/form4-12092022_091256.xml…